Yuyang Yan

Yuyang Yan

Auto-generated profile, based on publicly available information

Yuyang Yan

Institute of Data Science, Maastricht University, The Netherlands

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2024 in Applied Acoustics
Verified
Journal Article
Open access
YYYuyang Yan
Yuyang Yan
SSSami O. Simons
Sami O. Simons
LBLoes van Bemmel
Loes van Bemmel
LRLauren G. Reinders
Lauren G. Reinders
FFFrits M.E. Franssen
Frits M.E. Franssen
VUVisara Urovi
Visara Urovi

1 May 2025 in Computer Methods and Programs in Biomedicine
Verified
Journal Article
Open access
YYYuyang Yan
Yuyang Yan
LBLoes van Bemmel
Loes van Bemmel
FFFrits M.E. Franssen
Frits M.E. Franssen
SSSami O. Simons
Sami O. Simons
VUVisara Urovi
Visara Urovi
Deteriorations in respiratory health, also known as exacerbations, are important events in the progression of chronic respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD) and asthma. Changes in vocal characteristics during episodes of respiratory distress suggest that voice analysis could be a valuable tool for monitoring exacerbations. This study aims to develop a remote monitoring method for automatically detecting exacerbations in COPD and asthma patients using only speech data. This study proposes a speech-based approach for remote monitoring of asthma and COPD exacerbations, leveraging optimized Mel-Frequency Cepstral Coefficients (MFCC) alongside multi-domain acoustic features. We demonstrate that the optimized MFCC outperforms state-of-the-art feature extraction techniques, while integrating complementary features from the time, frequency, energy, and spectral domains further enhances predictive accuracy. To ensure model transparency and facilitate clinical adoption, we employ SHapley Additive exPlanations (SHAP) to identify key speech biomarkers contributing to exacerbation detection. Compared with the state-of-the-art methods, our method exhibits excellent classification performance with an accuracy of 0.892 and an AUC of 0.955 on the TACTICAS dataset. Moreover, the most salient features ranked by SHAP values are MFCC-related features and energy features, which explains the reason behind the improvement observed with feature fusion. Comprehensive experiments and comparisons with existing algorithms highlight the potential of speech-based monitoring for respiratory conditions in real-world settings. The proposed method outperforms state-of-the-art approaches, offering a promising avenue for exacerbation diagnosis and monitoring while potentially reducing the burden on both patients and healthcare providers.

11 August 2024
Verified
Journal Article
Open access
PDF file
YYYuyang Yan
Yuyang Yan
WAWafaa Aljbawi
Wafaa Aljbawi
SSSami O. Simons
Sami O. Simons
VUVisara Urovi
Visara Urovi
Aim: COVID-19 has affected more than 223 countries worldwide and in the post-COVID era, there is a pressing need for non-invasive, low-cost, and highly scalable solutions to detect COVID-19. This study focuses on the analysis of voice features and machine learning models in the automatic detection of COVID-19. Methods: We develop a deep learning model to identify COVID-19 from voice recording data. The novelty of this work is in the development of deep learning models for COVID-19 identification from only voice recordings. We use the Cambridge COVID-19 Sound database which contains 893 speech samples, crowd-sourced from 4,352 participants via a COVID-19 Sounds app. Voice features including Mel-spectrograms and Mel-frequency cepstral coefficients (MFCC) and convolutional neural network (CNN) Encoder features are extracted. Based on the voice data, we develop deep learning classification models to detect COVID-19 cases. These models include long short-term memory (LSTM), CNN and Hidden-Unit BERT (HuBERT). Results: We compare their predictive power to baseline machine learning models. HuBERT achieves the highest accuracy of 86% and the highest AUC of 0.93. Conclusions: The results achieved with the proposed models suggest promising results in COVID-19 diagnosis from voice recordings when compared to the results obtained from the state-of-the-art.

21 April 2026 in Respiratory Medicine
Verified
Journal Article
Open access
MNMikołaj Najda
Mikołaj Najda
YYYuyang Yan
Yuyang Yan
LBLoes van Bemmel
Loes van Bemmel
FFFrits M.E. Franssen
Frits M.E. Franssen
SSSami O. Simons
Sami O. Simons
VUVisara Urovi
Visara Urovi
COPD and asthma cause significant morbidity and mortality across the globe. The development of non-invasive telemonitoring solutions offers the potential to improve patient care. To examine whether breathing and speech patterns extracted from audio recordings enhance model generalizability of distinguishing stable from exacerbation periods in COPD and asthma. Patterns related to breathing and speech were extracted from a dataset that combined daily audio speech recordings with a patient-reported outcome measure (EXACT). Medical experts categorized patient health status as stable or exacerbation. A tree-based model was investigated for exacerbation prediction. The model was trained on signal-related features, breathing and speech patterns, and combination of both. Results were examined for variability among all people and feature importance. The study included 21 people (mean age 62.7 years; 66.7% female), 61.9% diagnosed with COPD and 38.1% with asthma. Minimum breath duration and speech duration differed between stable and exacerbation states (p < 0.05). The model, trained on combined features sets achieved Sensitivity of 0.78, 0.10 SD exceeding models trained on acoustic-only (0.70, 0.17 SD) and patterns-only sets (0.68, 0.13 SD). Inconsistencies were observed in patient-level results across exacerbation severity. Speech Duration, Spectral Contrast, Harmonic to Noise Ratio, Breath Group Duration and 26 Mel-Frequency Cepstral Coefficient were found to have the highest importance for the best performing model. Combining signal derived features with breathing and speech patterns helps models to achieve higher results. Detected clusters within the study group indicate patient-level variability. Presented results position breathing and speech patterns as valuable tool for remote patient screening.

14 September 2024 in European Respiratory Journal
Verified
Conference Paper
Closed access
YYYuyang Yan
Yuyang Yan
LBLoes Van Bemmel
Loes Van Bemmel
SSSami O. Simons
Sami O. Simons
VUVisara Urovi
Visara Urovi
Introduction: Deteriorations in respiratory health, also called exacerbations, are important events in the natural history of individuals living with chronic respiratory diseases such as COPD and asthma. Aim: Voice is known to change during respiratory distress. We hypothesized that exacerbations of COPD and asthma can be detected by AI models using voice as input. The aim was to train a machine-learning model for the detection of COPD and asthma exacerbations solely using speech recordings. Methods: We used the TACTICAS dataset which contains speech recordings from Dutch COPD and asthma patients, who had their voice collected daily via a mobile application for 3 months. Besides voice, an EXACT questionnaire was completed daily. Acoustic features, specifically Mel-frequency cepstral coefficients (MFCC), were extracted from speech recordings. Subsequently, a K-Nearest Neighbors (KNN) algorithm was developed using 10-fold cross-validation to predict the EXACT event. Results: The TACTICAS dataset contained 5460 speech recordings from 38 participants (18 COPD and 20 asthma), 1670 recordings could be classified as EXACT events and 3786 recordings were classified as non-EXACT events. The developed EXACT event classification model achieved an accuracy of 88.7% (SD: ±0.02), a sensitivity of 85.4% (SD: ±0.04), a specificity of 90.1% (SD: ±0.02), and an AUC score of 87.8% (SD: ±0.02) averaged across all folds. Conclusions: Exacerbations of asthma and COPD can be accurately detected using only the voice, hence opening up possibilities for patient monitoring through daily speech recordings. Funding: the TACTIAS study was sponsored by an unrestricted research grant from AstraZeneca and Boehringer Ingelheim.